Skip to main content
HairCited

Minoxidil.

V C Fiedler-Weiss
Review Dermatologic clinics 1987
PubMed
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D3301118'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Type d'étude
Controlled Clinical Trial
Population
hypertensive patients
Intervention
Minoxidil. None
Comparateur
None
Critère de jugement principal
growth
Direction de l'effet
Mixed
Risque de biais
Moderate

Abstract

Topical minoxidil has shown some promise for the treatment of male-pattern alopecia and alopecia areata. Clinical trials suggest that careful patient selection and appropriate drug formulation are both important factors to maximize efficacy. Side effects attributable to topical minoxidil appear to consist almost entirely of cutaneous reactions in patients who have been studied thus far, i.e., patients without hypertension or cardiovascular disease. The mechanism of minoxidil-induced hair regrowth is not fully understood, but it may involve a synergistic effect of minoxidil on a variety of cell types.

En bref

Clinical trials suggest that careful patient selection and appropriate drug formulation are both important factors to maximize efficacy, and the mechanism of minoxidil-induced hair regrowth is not fully understood, but it may involve a synergistic effect on a variety of cell types.

Used In Evidence Reviews

Similar Papers